CURIS LIFESCIENCES LTD Valuation
CURIS · Healthcare · Current price ₹109
Is CURIS LIFESCIENCES LTD undervalued?
DocStoX estimates the fair value of CURIS LIFESCIENCES LTD at ₹202 per share, versus the current market price of ₹109. That puts the stock about +85.2% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹166), Relative P/E (₹327), Graham floor (₹106). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹106 (bear) to ₹202 (base) to ₹327 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
CURIS LIFESCIENCES LTD trades at a P/E of 10.6x and a P/B of 1.7x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on CURIS LIFESCIENCES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.